Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
The latest announcement is out from Atomo Diagnostics Ltd. ( (AU:AT1) ).
Atomo Diagnostics Limited has successfully completed a capital raise of up to $3.1 million through a share placement and share purchase plan, supported by existing shareholders. This capital raise aims to support the company’s general working capital needs and involves issuing new shares and options, with a board restructure and operational review expected to result in further cost savings and strategic alignment.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Limited is a company operating in the medical diagnostics industry, focusing on the development and commercialization of rapid diagnostic test devices. The company is listed on the Australian Securities Exchange (ASX) under the ticker AT1.
Average Trading Volume: 450,155
Technical Sentiment Signal: Buy
Current Market Cap: A$12.78M
Find detailed analytics on AT1 stock on TipRanks’ Stock Analysis page.